{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:27:36Z","timestamp":1785461256572,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Argentinean National Cancer Institute"},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP-0337\/2013"],"award-info":[{"award-number":["PIP-0337\/2013"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5583-7","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T13:03:10Z","timestamp":1556024590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Factors associated with low adherence to cervical cancer follow-up retest among HPV+\/ cytology negative women: a study in programmatic context in a low-income population in Argentina"],"prefix":"10.1186","volume":"19","author":[{"given":"Juan","family":"Gago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Arrossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"issue":"4","key":"5583_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1590\/S1020-49892010001000003","volume":"28","author":"S Arrossi","year":"2010","unstructured":"Arrossi S, Paolino M, Sankaranarayanan R. Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina. Rev Panam Salud Publica. 2010;28(4):249\u201357.","journal-title":"Rev Panam Salud Publica"},{"key":"5583_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.vaccine.2006.05.061","volume":"24","author":"EL Franco","year":"2006","unstructured":"Franco EL, Cuzick J, Hildesheim A, de Sanjose S. Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine. 2006;24:171\u20137. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.061\n                    \n                  .","journal-title":"Vaccine."},{"issue":"14","key":"5583_CR3","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","volume":"360","author":"R Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385\u201394. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0808516\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"Suppl 10","key":"5583_CR4","doi-asserted-by":"publisher","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","volume":"26","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008;26(Suppl 10):K29\u201341. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.019\n                    \n                  .","journal-title":"Vaccine."},{"key":"5583_CR5","unstructured":"WHO. Comprehensive cervical cancer control: A guide to essential practice: WHO. \n                    http:\/\/www.who.int\/cancer\/publications\/9241547006\/en\/\n                    \n                  . Accessed 25 Sept 2018."},{"key":"5583_CR6","doi-asserted-by":"publisher","unstructured":"Bergeron C, Giorgi-Rossi P, Cas F, et al. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial. J Natl Cancer Inst. 2015;107(2). \n                    https:\/\/doi.org\/10.1093\/jnci\/dju423\n                    \n                  .","DOI":"10.1093\/jnci\/dju423"},{"key":"5583_CR7","unstructured":"Arrossi S, Thouyaret L, Paul L. Prevenci\u00f3n del c\u00e1ncer cervicouterino: recomendaciones para el tamizaje, seguimiento y tratamiento de mujeres en el marco de programas de tamizaje basados en el test de VPH. Actualizaci\u00f3n. Buenos Aires, Ministerio de Salud: 2015;20."},{"issue":"10","key":"5583_CR8","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/bjc.2017.309","volume":"117","author":"NJ Polman","year":"2017","unstructured":"Polman NJ, Veldhuijzen NJ, Heideman DAM, Snijders PJF, Meijer CJLM, Berkhof J. HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test. Br J Cancer. 2017;117(10):1557\u201361. \n                    https:\/\/doi.org\/10.1038\/bjc.2017.309\n                    \n                  .","journal-title":"Br J Cancer"},{"issue":"10","key":"5583_CR9","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/ijc.29290","volume":"136","author":"MH Uijterwaal","year":"2015","unstructured":"Uijterwaal MH, Polman NJ, Witte BI, et al. Triaging HPV-positive women with normal cytology by p16\/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Int J Cancer. 2015;136(10):2361\u20138. \n                    https:\/\/doi.org\/10.1002\/ijc.29290\n                    \n                  .","journal-title":"Int J Cancer"},{"issue":"3","key":"5583_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ijc.26056","volume":"130","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart DC, Berkhof J, van Kemenade FJ, et al. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer. 2012;130(3):602\u201310. \n                    https:\/\/doi.org\/10.1002\/ijc.26056\n                    \n                  .","journal-title":"Int J Cancer"},{"key":"5583_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ypmed.2018.08.005","volume":"115","author":"LH Alba","year":"2018","unstructured":"Alba LH, D\u00edaz S, Gamboa O, et al. Accuracy of mammography and clinical breast examination in the implementation of breast cancer screening programs in Colombia. Prev Med. 2018;115:19\u201325. \n                    https:\/\/doi.org\/10.1016\/j.ypmed.2018.08.005\n                    \n                  .","journal-title":"Prev Med"},{"key":"5583_CR12","doi-asserted-by":"publisher","unstructured":"Gage JC, Schiffman M, Katki HA, et al. Reassurance against future risk of Precancer and Cancer conferred by a negative human papillomavirus test. J Natl Cancer Inst. 2014;106(8). \n                    https:\/\/doi.org\/10.1093\/jnci\/dju153\n                    \n                  .","DOI":"10.1093\/jnci\/dju153"},{"issue":"40","key":"5583_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jncimonographs\/lgq008","volume":"2010","author":"R Anhang Price","year":"2010","unstructured":"Anhang Price R, Zapka J, Edwards H, Taplin SH. Organizational factors and the cancer screening process. J Natl Cancer Inst Monogr. 2010;2010(40):38\u201357. \n                    https:\/\/doi.org\/10.1093\/jncimonographs\/lgq008\n                    \n                  .","journal-title":"J Natl Cancer Inst Monogr"},{"key":"5583_CR14","doi-asserted-by":"crossref","unstructured":"Arrossi S, Paolino M, Laudi R, et al. Effect of programmatic HPV-testing in Cervical Cancer Prevention in the Jujuy Demonstration Project in Argentina: a Population-based, Quasi-experimental, Before and After Retrospective Cohort Study. Lancet Global Health. 2019; In Press.\u00a0","DOI":"10.1016\/S2214-109X(19)30048-8"},{"issue":"2","key":"5583_CR15","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2214-109X(14)70354-7","volume":"3","author":"S Arrossi","year":"2015","unstructured":"Arrossi S, Thouyaret L, Herrero R, et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob Health. 2015;3(2):e85\u201394. \n                    https:\/\/doi.org\/10.1016\/S2214-109X(14)70354-7\n                    \n                  .","journal-title":"Lancet Glob Health"},{"key":"5583_CR16","doi-asserted-by":"publisher","unstructured":"Arrossi S, Paolino M, Thouyaret L, Laudi R, Campanera A. Evaluation of scaling-up of HPV self-collection offered by community health workers at home visits to increase screening among socially vulnerable under-screened women in Jujuy Province, Argentina. Implement Sci. 2017;12. \n                    https:\/\/doi.org\/10.1186\/s13012-017-0548-1\n                    \n                  .","DOI":"10.1186\/s13012-017-0548-1"},{"issue":"6","key":"5583_CR17","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/bjc.2017.248","volume":"117","author":"EA Burger","year":"2017","unstructured":"Burger EA, Pedersen K, Sy S, Kristiansen IS, Kim JJ. Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway. Br J Cancer. 2017;117(6):783\u201390. \n                    https:\/\/doi.org\/10.1038\/bjc.2017.248\n                    \n                  .","journal-title":"Br J Cancer"},{"issue":"1","key":"5583_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0124-00642010000100001","volume":"12","author":"C Wiesner","year":"2010","unstructured":"Wiesner C, Cendales R, Murillo R, Pi\u00f1eros M, Tovar S. Following-up females having an abnormal pap smear in Colombia. Rev Salud Publica Bogota. 2010;12(1):1\u201313.","journal-title":"Rev Salud Publica Bogota"},{"key":"5583_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ypmed.2017.12.023","volume":"109","author":"KA Rendle","year":"2018","unstructured":"Rendle KA, Schiffman M, Cheung LC, et al. Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting. Prev Med. 2018;109:44\u201350. \n                    https:\/\/doi.org\/10.1016\/j.ypmed.2017.12.023\n                    \n                  .","journal-title":"Prev Med"},{"issue":"1","key":"5583_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0969141314561707","volume":"22","author":"L Pasquale","year":"2015","unstructured":"Pasquale L, Giorgi Rossi P, Carozzi F, et al. Cervical cancer screening with HPV testing in the Valcamonica (Italy) screening programme. J Med Screen. 2015;22(1):38\u201348. \n                    https:\/\/doi.org\/10.1177\/0969141314561707\n                    \n                  .","journal-title":"J Med Screen"},{"issue":"3","key":"5583_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0969141316663580","volume":"24","author":"B Passamonti","year":"2017","unstructured":"Passamonti B, Gustinucci D, Giorgi Rossi P, et al. Cervical human papilloma virus (HPV) DNA primary screening test: results of a population-based screening programme in Central Italy. J Med Screen. 2017;24(3):153\u201362. \n                    https:\/\/doi.org\/10.1177\/0969141316663580\n                    \n                  .","journal-title":"J Med Screen"},{"issue":"1","key":"5583_CR22","doi-asserted-by":"publisher","first-page":"e0147326","DOI":"10.1371\/journal.pone.0147326","volume":"11","author":"M Rebolj","year":"2016","unstructured":"Rebolj M, Bonde J, Preisler S, Ejegod D, Rygaard C, Lynge E. Human papillomavirus assays and cytology in primary cervical screening of women aged 30 years and above. PLoS One. 2016;11(1):e0147326. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147326\n                    \n                  .","journal-title":"PLoS One"},{"key":"5583_CR23","volume-title":"Health, United States, 2016: With Chartbook on Long-Term Trends in Health","author":"National Center for Health Statistics (US)","year":"2017","unstructured":"National Center for Health Statistics (US). Health, United States, 2016: With Chartbook on Long-Term Trends in Health. Hyattsville (MD): National Center for Health Statistics (US); 2017. \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK453378\/\n                    \n                  . Accessed 18 Sept 2018"},{"key":"5583_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ypmed.2017.05.004","volume":"100","author":"M Watson","year":"2017","unstructured":"Watson M, Benard V, King J, Crawford A, Saraiya M. National assessment of HPV and pap tests: changes in cervical cancer screening, National Health Interview Survey. Prev Med. 2017;100:243\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ypmed.2017.05.004\n                    \n                  .","journal-title":"Prev Med"},{"issue":"6","key":"5583_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000452240","volume":"60","author":"LW Musselwhite","year":"2016","unstructured":"Musselwhite LW, Oliveira CM, Kwaramba T, et al. Racial\/ethnic disparities in cervical Cancer screening and outcomes. Acta Cytol. 2016;60(6):518\u201326. \n                    https:\/\/doi.org\/10.1159\/000452240\n                    \n                  .","journal-title":"Acta Cytol"},{"issue":"2","key":"5583_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/pon.4126","volume":"26","author":"AJ Chorley","year":"2017","unstructured":"Chorley AJ, Marlow LAV, Forster AS, Haddrell JB, Waller J. Experiences of cervical screening and barriers to participation in the context of an organised programme: a systematic review and thematic synthesis. Psychooncology. 2017;26(2):161\u201372. \n                    https:\/\/doi.org\/10.1002\/pon.4126\n                    \n                  .","journal-title":"Psychooncology."},{"key":"5583_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.10400","volume-title":"Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force","author":"J Melnikow","year":"2018","unstructured":"Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Soulsby MA. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality (US); 2018. \n                    http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526306\/\n                    \n                  . Accessed 5 Nov 2018."},{"issue":"3","key":"5583_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1590\/S1851-82652012000400003","volume":"8","author":"M Paolino","year":"2012","unstructured":"Paolino M, Arrossi S. Analysis of the reasons for abandoning the follow-up and treatment process in women with pre-cancerous cervical lesions in the province of Jujuy: implications for health management. Salud Colect. 2012;8(3):247\u201361. \n                    https:\/\/doi.org\/10.1590\/S1851-82652012000400003\n                    \n                  .","journal-title":"Salud Colect"},{"issue":"1","key":"5583_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1590\/S1020-49892005000600012","volume":"18","author":"IG Dzuba","year":"2005","unstructured":"Dzuba IG, Calder\u00f3n R, Bliesner S, Luciani S, Amado F, Jacob M. A participatory assessment to identify strategies for improved cervical cancer prevention and treatment in Bolivia. Rev Panam Salud Publica. 2005;18(1):53\u201363.","journal-title":"Rev Panam Salud Publica"},{"issue":"6","key":"5583_CR30","first-page":"437","volume":"34","author":"M Paolino","year":"2013","unstructured":"Paolino M, Sankaranarayanan R, Arrossi S. Social determinants of dropout from diagnosis and treatment by women with abnormal pap smears in Buenos Aires, Argentina. Rev Panam Salud Publica. 2013;34(6):437\u201345.","journal-title":"Rev Panam Salud Publica"},{"key":"5583_CR31","doi-asserted-by":"publisher","unstructured":"Paz-Sold\u00e1n VA, Bayer AM, Nussbaum L, Cabrera L. Structural barriers to screening for and treatment of cervical cancer in Peru. Reprod Health Matters. 2012;20(40). \n                    https:\/\/doi.org\/10.1016\/S0968-8080(12)40680-2\n                    \n                  .","DOI":"10.1016\/S0968-8080(12)40680-2"},{"issue":"4","key":"5583_CR32","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10935-018-0513-z","volume":"39","author":"JS Luque","year":"2018","unstructured":"Luque JS, Tarasenko YN, Chen C. Correlates of cervical Cancer screening adherence among women in the U.S.: findings from HINTS 2013\u20132014. J Prim Prev. 2018;39(4):329\u201344. \n                    https:\/\/doi.org\/10.1007\/s10935-018-0513-z\n                    \n                  .","journal-title":"J Prim Prev"},{"issue":"46","key":"5583_CR33","doi-asserted-by":"publisher","first-page":"81455","DOI":"10.18632\/oncotarget.20188","volume":"8","author":"N Li","year":"2017","unstructured":"Li N, Hang D, Yang L, et al. Persistence of type-specific human papillomavirus infection among Daqing City women in China with normal cytology: a pilot prospective study. Oncotarget. 2017;8(46):81455\u201361. \n                    https:\/\/doi.org\/10.18632\/oncotarget.20188\n                    \n                  .","journal-title":"Oncotarget."},{"issue":"6","key":"5583_CR34","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.30507","volume":"123","author":"AL Beavis","year":"2017","unstructured":"Beavis AL, Gravitt PE, Rositch AF. Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States. Cancer. 2017;123(6):1044\u201350. \n                    https:\/\/doi.org\/10.1002\/cncr.30507\n                    \n                  .","journal-title":"Cancer."},{"issue":"4","key":"5583_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1159\/000338555","volume":"56","author":"ME Skaznik-Wikiel","year":"2012","unstructured":"Skaznik-Wikiel ME, Sukumvanich P, Austin RM, et al. Heavy cervical cancer burden in elderly women: how can we improve the situation? Acta Cytol. 2012;56(4):388\u201393. \n                    https:\/\/doi.org\/10.1159\/000338555\n                    \n                  .","journal-title":"Acta Cytol"},{"key":"5583_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12889-016-3474-2","volume":"16","author":"S Arrossi","year":"2016","unstructured":"Arrossi S, Ramos S, Straw C, Thouyaret L, Orellana L. HPV testing: a mixed-method approach to understand why women prefer self-collection in a middle-income country. BMC Public Health. 2016;16:832. \n                    https:\/\/doi.org\/10.1186\/s12889-016-3474-2\n                    \n                  .","journal-title":"BMC Public Health"},{"issue":"6","key":"5583_CR37","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.cdp.2003.09.004","volume":"27","author":"JC Gage","year":"2003","unstructured":"Gage JC, Ferreccio C, Gonzales M, Arroyo R, Huiv\u00edn M, Robles SC. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev. 2003;27(6):466\u201371.","journal-title":"Cancer Detect Prev"},{"issue":"1","key":"5583_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13063-019-3229-3","volume":"20","author":"S Arrossi","year":"2019","unstructured":"Arrossi S, Paolino M, Orellana L, Thouyaret L, Kohler RE, Viswanath K. Mixed-methods approach to evaluate an mHealth intervention to increase adherence to triage of human papillomavirus-positive women who have performed self-collection (the ATICA study): study protocol for a hybrid type I cluster randomized effectiveness-implementation trial. Trials. 2019;20(1):148. \n                    https:\/\/doi.org\/10.1186\/s13063-019-3229-3\n                    \n                  .","journal-title":"Trials"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5583-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5583-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T23:11:59Z","timestamp":1587510719000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5583-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5583"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5583-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"7 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This protocol has been approved by the CEMIC Institutional Review Board (Protocol number 1186). Identity of participants has been preserved by de-identification of the databases. Verbal informed consent has been obtained according to the national regulations for standard medical practices (Patient\u2019s Rights Act 26.529). The requirement of specific consent does not apply for statistical analysis of aggregated de-identified data (Res. 1480\/2011 Ministry of Health).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"367"}}